BioCentury | Dec 5, 2011
Company News
MabCure, Biotech Investment deal
...will also issue MabCure 15% of its outstanding shares. MabCure Inc. (OTCBB:MBCI), New York, N.Y. Biotech Investment Corp....
Products & Solutions
About Biocentury
Contact
Privacy & Legal
- Follow Us
